
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Remove Advertising filter Advertising (8)
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- Remove OTC medicines filter OTC medicines (31)
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Benzocaine: proposed advisory statements for medicines
Closed on 16 October 2018
Proposed therapeutic goods advertising code guidance
Closed on 4 October 2018
Complaints handling - Advertising therapeutic goods to the public
Closed on 4 June 2018
Draft therapeutic goods advertising code 2018 and associated guidelines
Closed on 27 April 2018
Therapeutic Goods Advertising Code
Closed on 13 October 2017
The Scheduling Policy Framework and Advertising of Pharmacist-only medicines (Schedule 3 substances)
Closed on 28 April 2017
The regulatory framework for advertising therapeutic goods - November 2016
Closed on 21 December 2016
Paracetamol and ibuprofen: advisory statements for medicines
Closed on 22 November 2016
Non-steroidal anti-inflammatory drugs: proposed additional advisory statement
Closed on 22 November 2016
cimetidine, famotidine, nizatidine and ranitidine: corrected advisory statement for medicines
Closed on 29 October 2015